Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023)
- Autor:
- Autor USP: FERNANDES, ANDREA BALAN - ICB
- Unidade: ICB
- DOI: 10.1016/s0140-6736(23)00510-x
- Subjects: MICROBIOLOGIA; HORMÔNIOS DO CÓRTEX ADRENAL; COVID-19; ANÓXIA; ESTUDOS RANDOMIZADOS; ANTI-INFLAMATÓRIOS; FÁRMACOS IMUNOSSUPRESSORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Lancet
- ISSN: 1474-547X
- Volume/Número/Paginação/Ano: v. 401, p. 1499-1507, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
BALAN, Andrea. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, v. 401, p. 1499-1507, 2023Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(23)00510-x. Acesso em: 29 maio 2024. -
APA
Balan, A. (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401, 1499-1507. doi:10.1016/s0140-6736(23)00510-x -
NLM
Balan A. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial [Internet]. The Lancet. 2023 ; 401 1499-1507.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/s0140-6736(23)00510-x -
Vancouver
Balan A. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial [Internet]. The Lancet. 2023 ; 401 1499-1507.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/s0140-6736(23)00510-x - From a metagenomic source to a high-resolution structure of a novel alkaline esterase
- Est16, a new esterase isolated from a metagenomic library of a microbial consortium specializing in diesel oil degradation
- Characterization of EST3: a metagenome-derived esterase with suitable properties for biotechnological applications
- Structural features of PhoX, one of the phosphate-binding proteins from Pho regulon of Xanthomonas citri
- The periplasmic binding protein NrtT affects xantham gum production and pathogenesis in Xanthomonas citri
- Sistema suicida para leveduras baseado na degradação do material genético visando biossegurança
- The sulfur/sulfonates transport systems in Xanthomonas citri pv. citri
- Sistema suicida para leveduras baseado na degradação do material genético visando biossegurança
- Isolamento e caracterização de fagos de Streptomyces
- Mycobacterium tuberculosis CysA2 is a dual sulfurtransferase with activity against thiosulfate and 3-mercaptopyruvate and interacts with mammalian cells
Informações sobre o DOI: 10.1016/s0140-6736(23)00510-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
